Innova Vascular
Irvine, US · Delaware corporation
Innova Vascular is a medical device company focused on the vascular space, led by a founder with a background in developing and commercializing vascular medical devices. The page provides limited detail about the company's specific products.
HealthtechMedical Devices
Founders & leadership
SS
Sanjay ShrivastavaFounder & CEO
MH
Mike HennessyDirector
OO
Owen O'NeillDirector
Competitors · 10
by search overlapEvtoday55 shared keywords
Massdevice51 shared keywordsMassDevice is a news and media outlet covering the medical device industry, publishing articles, special reports, and white papers on medtech companies, products, and regulatory topics such as FDA 510(k) submissions. It serves medical device professionals with industry news and analysis.
Fda47 shared keywords
EndoSense32 shared keywords
Diabetes Prevention Program32 shared keywords
Boston Scientific31 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Vantis Vascular29 shared keywordsVantis Vascular develops vascular intervention technology, including the CrossFast integrated vascular delivery system with an auto-locking inner monorail microcatheter and outer delivery catheter for complex PCI procedures. Founded by physicians, the company is also developing next-generation intravascular lithotripsy (IVL) and peripheral below-the-knee (BTK) solutions for vascular interventionalists.</parameter>
<parameter name="founders">[{"full_name": "Jason Turner", "title": "Chief Executive Officer"}, {"full_name": "Tim Fischell", "title": "Chief Medical Officer"}, {"full_name": "Frank Saltiel", "title": "Chief Clinical Officer"}, {"full_name": "Gary McCord", "title": "Chief Commercial Officer"}, {"full_name": "Mike Mirizzi", "title": "Chief Technology Officer"}, {"full_name": "Marc Monahan", "title": "Chief Financial Officer"}]</parameter>
<parameter name="hq_city">San Jose
NeuroVasc26 shared keywordsNeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions. The company serves patients and healthcare providers requiring neurovascular interventions.
Bioworld25 shared keywordsBioWorld publishes news and data on the biopharmaceutical and drug development industry, covering topics such as clinical trials, licensing deals, oncology pipelines, and gene therapies. It serves biopharma and life sciences professionals through industry reporting and market intelligence.
Mapquest25 shared keywordsProvider of geographical information systems and services; acquired by America Online.
Companies competing with Innova Vascular for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$5.7MraisedJul 2025 · 10 investors · Other TechnologyRule 506(b)
▶$5.7MraisedJul 2025 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Owen O'NeillDirector
- Sanjay ShrivastavaExecutive Officer, Director
- Mike HennessyDirector
- Offering amount
- $5.7M
- Amount sold
- $5.7M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedJul 2025 · 5 investors · Other TechnologyRule 506(b)
▶$10MraisedJul 2025 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Sanjay ShrivastavaExecutive Officer, Director
- Owen O'NeillDirector
- Mike HennessyDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- May 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedJul 2025 · 1 investors · Other TechnologyRule 506(b)
▶$4MraisedJul 2025 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Sanjay ShrivastavaExecutive Officer, Director
- Mike HennessyDirector
- Owen O'NeillDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedJul 2025 · 2 investors · Other TechnologyRule 506(b)
▶$2.2MraisedJul 2025 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mike HennessyDirector
- Owen O'NeillDirector
- Sanjay ShrivastavaExecutive Officer, Director
- Offering amount
- $2.2M
- Amount sold
- $2.2M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.